MYEG

Non-binding Vaccine Registration of Interest


    MYEG would like to invite non-binding indication of interest from employers to assess the market demand for vaccine Zifivax™, a Covid-19 vaccine developed in China, under the proposed private vaccination programme.

    This is only an indication of interest for assessing market demand, and is not a binding placement or acceptance of order in any way. There will be no obligation by any party by virtue of this registration.

    ZF2001, which is also known by its trade-name Zifivax™, is an adjuvanted protein sub-unit Covid-19 vaccine.

    The vaccine is developed by Anhui Zhifei Longcom Biopharmaceutical Co. Ltd. in collaboration with the Institute of Microbiology at the Chinese Academy of Sciences, and is the fifth Chinese government-approved Emergency Use Authorisation (EUA) vaccine in China.


Non-binding Vaccine Registration of Interest

Important Notice:

By registering your interest here, you hereby allow MYEG and its group of companies and associates to use the information provided herein for its assessment and processing, and for MYEG representatives to contact you for marketing purposes
when the vaccine becomes available.

0/0
0/0
0/0
0/0
0/0
0/0
0/0